SmithKline Beecham to distribute Trinity's tests:
This article was originally published in Clinica
Executive Summary
SmithKline Beecham International is to distribute Trinity Biotech's SeroCard and SalivaCard rapid HIV tests in certain African countries. SmithKline Beecham will purchase an agreed annual quantity of the products from Trinity and will sell the products under its own label. SKB will be responsible for attaining regulatory approvals. If successful, the companies intend to expand the agreement to a broader product offering. Irish company Trinity Biotech manufactures and markets rapid tests for the point of care, over-the-counter and the clinical laboratory markets.